Edwards Lifesciences Corp.

Edwards Lifesciences Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
209.39 M
Public Float
187.81 M
Edwards Lifesciences Corp.
Stock Exchange New York Stock Exchange
EPS
$3.59
Market Cap
$39.26 B
Shares Outstanding
208.5 M
Public Float
206.21 M

Profile

Address
One Edwards Way
Irvine California 92614
United States
Employees -
Website http://www.edwards.com
Updated 07/08/2019
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care.

Financials

View All
Created with Highcharts 5.0.14Edwards Lifesciences Corp.Net Income. Fiscal year is January-December. All values USD Millions.39239281181149549557057058458472272220132014201520162017201802004006008001000
Created with Highcharts 5.0.14Edwards Lifesciences Corp.Sales/Revenue. Fiscal year is January-December. All values USD Millions.2 0462 0462 3232 3232 4942 4942 9642 9643 4353 4353 7233 72320132014201520162017201801k2k3k4k

Michael A. Mussallem
Chairman & Chief Executive Officer
Leslie Stone Heisz
Independent Director